IRIS PubliCatt

Di Nardo, Lucia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 379
EU - Europa 244
AS - Asia 81
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 378
SE - Svezia 78
IT - Italia 43
SG - Singapore 37
CN - Cina 34
IE - Irlanda 32
DE - Germania 30
RU - Federazione Russa 20
GB - Regno Unito 14
FI - Finlandia 8
FR - Francia 7
CI - Costa d'Avorio 6
IN - India 6
NL - Olanda 4
BE - Belgio 3
HK - Hong Kong 2
AT - Austria 1
BR - Brasile 1
DK - Danimarca 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
ME - Montenegro 1
PA - Panama 1
SC - Seychelles 1
UA - Ucraina 1
Totale 713
Salva come PNG Salva come JPEG
Città #
Chandler 132
Ashburn 38
Dublin 32
New York 24
Singapore 20
Bremen 17
Milan 16
Moscow 15
Boston 12
Princeton 12
Redwood City 10
Beijing 9
San Mateo 9
Wilmington 8
Abidjan 6
Helsinki 6
Rome 6
Boardman 5
London 5
Pune 5
Amsterdam 4
Boydton 4
Bologna 3
Brussels 3
Paris 3
Southampton 3
Chicago 2
Edinburgh 2
Hong Kong 2
Lappeenranta 2
Marseille 2
Palazzolo sull'Oglio 2
Redmond 2
Vasto 2
Anchorage 1
Andover 1
Ann Arbor 1
Berlin 1
Besançon 1
Budapest 1
Busto Arsizio 1
Cambridge 1
Clearwater 1
Copenhagen 1
Dresden 1
Fairfield 1
Forio 1
Frankfurt am Main 1
Gunzenhausen 1
Houston 1
Kochi 1
Los Angeles 1
Lutzingen 1
Nuremberg 1
Panama City 1
Pescara 1
Piansano 1
Podgorica 1
Sacramento 1
Salerno 1
Seattle 1
Ventimiglia 1
Vienna 1
Wenzhou 1
Wernigerode 1
White Salmon 1
Woodbridge 1
Totale 456
Salva come PNG Salva come JPEG
Nome #
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 59
Therapeutic impact and management of persistent head and neck atopic dermatitis in dupilumab-treated patients 56
Coding and noncoding somatic mutations in candidate genes in basal cell carcinoma 49
Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies 46
Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis 45
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 38
Molecular alterations in basal cell carcinoma subtypes 38
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 37
Vitiligo-like lesions in patients with advanced breast cancer treated with cycline-dependent kinases 4 and 6 inhibitors 37
Intra-patient heterogeneity of BRAF and NRAS molecular alterations in primary melanoma and metastases 36
Melanoma types by in vivo reflectance confocal microscopy correlated with protein and molecular genetic alterations: A pilot study 35
Understanding the molecular genetics of basal cell carcinoma 32
Familial Melanoma: Diagnostic and Management Implications 31
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 30
Clinical, dermoscopic, and confocal features of nevi and melanomas in a multiple primary melanoma patient with the MITF p.E318K homozygous mutation 26
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 25
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 24
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study 19
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study 16
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study 15
Dupilumab-associated ocular adverse events are predicted by low tear break-up time and correlate with high IL-33 tear concentrations in patients with atopic dermatitis 14
The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab 12
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled 6
High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium 5
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study 4
Totale 735
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.893
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 2 0 0 0 0 0 2 2 1
2020/202132 0 0 2 0 0 24 2 1 1 0 2 0
2021/202283 1 1 1 6 7 1 1 10 3 7 21 24
2022/2023338 36 44 26 62 28 36 11 32 39 6 11 7
2023/2024261 7 46 27 34 16 28 9 8 9 6 36 35
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 735